col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Genomics
  original article Date Title Authors   All Authors
1 [GO] 2021―Oct―28 Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy Erick Gustavo Dorlass, Karine Lima Lourenço, Rubens Daniel Miserani Magalhães, Hugo Sato, Alex Fiorini, Renata Peixoto, et al. (+10)
2 [GO] 2021―Aug―18 Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age Meng Wu, Lingwei Ma, Liru Xue, Qingqing Zhu, Su Zhou, Jun Dai, et al. (+3)
3 [GO] 2021―Jul―20 CoVrimer: A tool for aligning SARS-CoV-2 primer sequences and selection of conserved/degenerate primers Merve Vural, Aslinur Akturk, Mert Demirdizen, Ronaldo Leka, Rana Acar, Ozlen Konu
4 [GO] 2021―May―19 Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns Jayanta Kumar Das, Swarup Roy
5 [GO] 2021―May―15 Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries Rui Wang, Jiahui Chen, Kaifu Gao, Guo-Wei Wei
6 [GO] 2021―Apr―08 ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections Luca Marcolungo, Cristina Beltrami, Chiara Degli Esposti, Giulia Lopatriello, Chiara Piubelli, Antonio Mori, et al. (+15)
7 [GO] 2021―Apr―07 Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality Jahad Alghamdi, Manal Alaamery, Tlili Barhoumi, Mamoon Rashid, Hala Alajmi, Nasser Aljasser, et al. (+15)
8 [GO] 2021―Jan―20 Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID19 therapy Henry Sung-Ching Wong, Chin-Lin Guo, Gan-Hong Lin, Kang-Yun Lee, Yukinori Okada, Wei-Chiao Chang
9 [GO] 2020―Dec―28 Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing Pingping Wang, Xiyun Jin, Wenyang Zhou, Meng Luo, Zhaochun Xu, Chang Xu, et al. (+8)
10 [GO] 2020―Dec―13 A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2 Umar Faruq Chowdhury, Mohammad Umer Sharif Shohan, Kazi Injamamul Hoque, Mirza Ashikul Beg, Mohammad Kawsar Sharif Siam, Mohammad Ali Moni
11 [GO] 2020―Nov―13 Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19 Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi, Zhumur Ghosh
12 [GO] 2020―Nov―05 Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus Chayan Roy, Santi M. Mandal, Suresh K. Mondal, Shriparna Mukherjee, Tarunendu Mapder, Wriddhiman Ghosh, Ranadhir Chakraborty
13 [GO] 2020―Oct―20 Variant analysis of the first Lebanese SARS-CoV-2 isolates Mhamad Abou-Hamdan, Kassem Hamze, Ali Abdel Sater, Haidar Akl, Nabil El-zein, Israa Dandache, Fadi Abdel-sater
14 [GO] 2020―Sep―30 Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour
15 [GO] 2020―Sep―20 Mutations on COVID-19 diagnostic targets Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
16 [GO] 2020―Sep―12 Molecular phylogeny and missense mutations of envelope proteins across coronaviruses Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy
17 [GO] 2020―Sep―10 SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design Sandeep Kumar Kushwaha, Veerbhan Kesarwani, Samraggi Choudhury, Sonu Gandhi, Shailesh Sharma
18 [GO] 2020―Sep―08 Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis Abdus Samad, Tamanna Jafar, Jahirul Hasnat Rafi
19 [GO] 2020―Aug―19 Missense mutations in SARS-CoV2 genomes from Indian patients Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy, Siddhartha Sankar Jana
20 [GO] 2020―Aug―07 Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach Pandiyan Muthuramalingam, Rajendran Jeyasri, Alaguvel Valliammai, Anthonymuthu Selvaraj, Chandrasekar Karthika, Shanmugaraj Gowrishankar, et al. (+3)
21 [GO] 2020―Jul―31 Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method Liqian Zhou, Juanjuan Wang, Guangyi Liu, Qingqing Lu, Ruyi Dong, Geng Tian, et al. (+2)
22 [GO] 2020―Jul―25 Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2 Namisha Sharma, Mehanathan Muthamilarasan, Ashish Prasad, Manoj Prasad
23 [GO] 2020―Jul―06 Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses Rabeb Touati, Sondes Haddad-Boubaker, Imen Ferchichi, Imen Messaoudi, Afef Elloumi Ouesleti, Henda Triki, et al. (+2)
24 [GO] 2020―Jul―05 SARS-CoV2 envelope protein: non-synonymous mutations and its consequences Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy
25 [GO] 2020―Jun―12 Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes Sk. Sarif Hassan, Pabitra Pal Choudhury, Pallab Basu, Siddhartha Sankar Jana
26 [GO] 2020―Apr―27 Genotyping coronavirus SARS-CoV-2: methods and implications Changchuan Yin


Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.005 sec